tiprankstipranks
Compass Pathways to be added to Nasdaq Biotechnology Index at open on 12/23
PremiumThe FlyCompass Pathways to be added to Nasdaq Biotechnology Index at open on 12/23
1M ago
Rising High: Organigram acquires Motif Labs for C$90M upfront
Premium
The Fly
Rising High: Organigram acquires Motif Labs for C$90M upfront
1M ago
Rising High: Cannabis firms report quarterly earnings
Premium
The Fly
Rising High: Cannabis firms report quarterly earnings
1M ago
Compass Pathways price target lowered to $60 from $120 at H.C. Wainwright
PremiumThe FlyCompass Pathways price target lowered to $60 from $120 at H.C. Wainwright
3M ago
Compass Pathways cuts 30% of workforce on Phase 3 trial delays
Premium
The Fly
Compass Pathways cuts 30% of workforce on Phase 3 trial delays
3M ago
Compass Pathways price target lowered to $18 from $23 at RBC Capital
Premium
The Fly
Compass Pathways price target lowered to $18 from $23 at RBC Capital
3M ago
Compass Pathways reports Q3 EPS (56c), consensus (57c)
PremiumThe FlyCompass Pathways reports Q3 EPS (56c), consensus (57c)
3M ago
Compass Pathways sees 2024 operating net cash use $114M-$120M
Premium
The Fly
Compass Pathways sees 2024 operating net cash use $114M-$120M
3M ago
Rising High: RIV Capital provides update on revenue, synergy realization
Premium
The Fly
Rising High: RIV Capital provides update on revenue, synergy realization
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100